In the present study, using genetically engineered mouse models (GEMM) and human gene expression data, we demonstrate the enrichment of MYBL2 expression and function in prostate cancers displaying phenotypic plasticity when compared with their adenocarcinoma counterparts. The gene discussed is MYBL2; the disease is prostate cancer.